talarozole   Click here for help

GtoPdb Ligand ID: 11381

Synonyms: R-115866 | R115866 | Rambazole®
Compound class: Synthetic organic
Comment: Talarozole (R115866) is a cytochrome P450 CYP26 inhibitor. It was investigated for clinical efficacy as a treatment for cutaneous inflammation, including psoriasis.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 83.87
Molecular weight 377.17
XLogP 4.89
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(C(n1cncn1)c1ccc(cc1)Nc1nc2c(s1)cccc2)CC
Isomeric SMILES CCC(C(n1cncn1)c1ccc(cc1)Nc1nc2c(s1)cccc2)CC
InChI InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)
InChI Key SNFYYXUGUBUECJ-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Talarozole progressed to phase 2 evaluation in acne [2] and psoriasis [3].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00716144 Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis Phase 2 Interventional GlaxoSmithKline
NCT00725439 An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne Phase 2 Interventional GlaxoSmithKline